N,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine

C139H303F3N28O36S17 — CID 161065223

IUPACN,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine
SMILESCC(C)S(=O)(=O)N1CC1.CC(C)S(=O)(=O)N1CCC(N(C)C)C1.CC(C)S(=O)(=O)N1CCC(N)C1.CC(C)S(=O)(=O)N1CCCC1.CC(C)S(=O)(=O)N1CCCCC1.CC(C)S(=O)(=O)N1CCCCCC1.CC(C)S(=O)(=O)N1CCCN(C)CC1.CC(C)S(=O)(=O)N1CCCNCC1.CC(C)S(=O)(=O)N1CCCOCC1.CC(C)S(=O)(=O)N1CCN(C)CC1.CC(C)S(=O)(=O)N1CCN(CC(F)(F)F)CC1.CC(C)S(=O)(=O)N1CCNCC1.CC(C)S(=O)(=O)N1CCOCC1.CC1CNCCCN1S(=O)(=O)C(C)C.CCN1CCCN(S(=O)(=O)C(C)C)CC1.CCN1CCCN(S(=O)(=O)C(C)C)CC1.CCN1CCN(S(=O)(=O)C(C)C)CC1
InChIInChI=1S/2C10H22N2O2S.C9H17F3N2O2S.4C9H20N2O2S.C9H19NO2S.2C8H18N2O2S.C8H17NO3S.C8H17NO2S.2C7H16N2O2S.C7H15NO3S.C7H15NO2S.C5H11NO2S/c2*1-4-11-6-5-7-12(9-8-11)15(13,14)10(2)3;1-8(2)17(15,16)14-5-3-13(4-6-14)7-9(10,11)12;1-8(2)14(12,13)11-6-5-9(7-11)10(3)4;1-9(2)14(12,13)11-6-4-5-10(3)7-8-11;1-8(2)14(12,13)11-6-4-5-10-7-9(11)3;1-4-10-5-7-11(8-6-10)14(12,13)9(2)3;1-9(2)13(11,12)10-7-5-3-4-6-8-10;1-8(2)13(11,12)10-6-4-9(3)5-7-10;1-8(2)13(11,12)10-6-3-4-9-5-7-10;1-8(2)13(10,11)9-4-3-6-12-7-5-9;1-8(2)12(10,11)9-6-4-3-5-7-9;1-7(2)12(10,11)9-5-3-8-4-6-9;1-6(2)12(10,11)9-4-3-7(8)5-9;1-7(2)12(9,10)8-3-5-11-6-4-8;1-7(2)11(9,10)8-5-3-4-6-8;1-5(2)9(7,8)6-3-4-6/h2*10H,4-9H2,1-3H3;8H,3-7H2,1-2H3;8-9H,5-7H2,1-4H3;9H,4-8H2,1-3H3;8-10H,4-7H2,1-3H3;9H,4-8H2,1-3H3;9H,3-8H2,1-2H3;8H,4-7H2,1-3H3;8-9H,3-7H2,1-2H3;8H,3-7H2,1-2H3;8H,3-7H2,1-2H3;7-8H,3-6H2,1-2H3;6-7H,3-5,8H2,1-2H3;7H,3-6H2,1-2H3;7H,3-6H2,1-2H3;5H,3-4H2,1-2H3
InChIKeyUDXYIYSWTVLRRK-UHFFFAOYSA-N
MW3545.25 g/mol
LogP7.46
Rot. Bonds39

About N,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine

N,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine (PubChem CID 161065223) has the molecular formula C139H303F3N28O36S17 and a molecular weight of 3545.25 g/mol. Its IUPAC name is N,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine.

Molecular Properties

Compound NameN,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine
PubChem CID161065223
Molecular FormulaC139H303F3N28O36S17
Molecular Weight3545.25 g/mol
Exact Mass3541.79
IUPAC NameN,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine
SMILESCC(C)S(=O)(=O)N1CC1.CC(C)S(=O)(=O)N1CCC(N(C)C)C1.CC(C)S(=O)(=O)N1CCC(N)C1.CC(C)S(=O)(=O)N1CCCC1.CC(C)S(=O)(=O)N1CCCCC1.CC(C)S(=O)(=O)N1CCCCCC1.CC(C)S(=O)(=O)N1CCCN(C)CC1.CC(C)S(=O)(=O)N1CCCNCC1.CC(C)S(=O)(=O)N1CCCOCC1.CC(C)S(=O)(=O)N1CCN(C)CC1.CC(C)S(=O)(=O)N1CCN(CC(F)(F)F)CC1.CC(C)S(=O)(=O)N1CCNCC1.CC(C)S(=O)(=O)N1CCOCC1.CC1CNCCCN1S(=O)(=O)C(C)C.CCN1CCCN(S(=O)(=O)C(C)C)CC1.CCN1CCCN(S(=O)(=O)C(C)C)CC1.CCN1CCN(S(=O)(=O)C(C)C)CC1
InChIInChI=1S/2C10H22N2O2S.C9H17F3N2O2S.4C9H20N2O2S.C9H19NO2S.2C8H18N2O2S.C8H17NO3S.C8H17NO2S.2C7H16N2O2S.C7H15NO3S.C7H15NO2S.C5H11NO2S/c2*1-4-11-6-5-7-12(9-8-11)15(13,14)10(2)3;1-8(2)17(15,16)14-5-3-13(4-6-14)7-9(10,11)12;1-8(2)14(12,13)11-6-5-9(7-11)10(3)4;1-9(2)14(12,13)11-6-4-5-10(3)7-8-11;1-8(2)14(12,13)11-6-4-5-10-7-9(11)3;1-4-10-5-7-11(8-6-10)14(12,13)9(2)3;1-9(2)13(11,12)10-7-5-3-4-6-8-10;1-8(2)13(11,12)10-6-4-9(3)5-7-10;1-8(2)13(11,12)10-6-3-4-9-5-7-10;1-8(2)13(10,11)9-4-3-6-12-7-5-9;1-8(2)12(10,11)9-6-4-3-5-7-9;1-7(2)12(10,11)9-5-3-8-4-6-9;1-6(2)12(10,11)9-4-3-7(8)5-9;1-7(2)12(9,10)8-3-5-11-6-4-8;1-7(2)11(9,10)8-5-3-4-6-8;1-5(2)9(7,8)6-3-4-6/h2*10H,4-9H2,1-3H3;8H,3-7H2,1-2H3;8-9H,5-7H2,1-4H3;9H,4-8H2,1-3H3;8-10H,4-7H2,1-3H3;9H,4-8H2,1-3H3;9H,3-8H2,1-2H3;8H,4-7H2,1-3H3;8-9H,3-7H2,1-2H3;8H,3-7H2,1-2H3;8H,3-7H2,1-2H3;7-8H,3-6H2,1-2H3;6-7H,3-5,8H2,1-2H3;7H,3-6H2,1-2H3;7H,3-6H2,1-2H3;5H,3-4H2,1-2H3
InChIKeyUDXYIYSWTVLRRK-UHFFFAOYSA-N
XLogP7.46
TPSA738.48 Ų
H-Bond Donors4
H-Bond Acceptors47
Rotatable Bonds39
Heavy Atoms223
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003545.25
LogP ≤ 57.46
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1047

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze N,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine?
The IUPAC name of N,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine (CID 161065223) is N,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine.
What is the SMILES notation for N,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine?
The canonical SMILES for N,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine is CC(C)S(=O)(=O)N1CC1.CC(C)S(=O)(=O)N1CCC(N(C)C)C1.CC(C)S(=O)(=O)N1CCC(N)C1.CC(C)S(=O)(=O)N1CCCC1.CC(C)S(=O)(=O)N1CCCCC1.CC(C)S(=O)(=O)N1CCCCCC1.CC(C)S(=O)(=O)N1CCCN(C)CC1.CC(C)S(=O)(=O)N1CCCNCC1.CC(C)S(=O)(=O)N1CCCOCC1.CC(C)S(=O)(=O)N1CCN(C)CC1.CC(C)S(=O)(=O)N1CCN(CC(F)(F)F)CC1.CC(C)S(=O)(=O)N1CCNCC1.CC(C)S(=O)(=O)N1CCOCC1.CC1CNCCCN1S(=O)(=O)C(C)C.CCN1CCCN(S(=O)(=O)C(C)C)CC1.CCN1CCCN(S(=O)(=O)C(C)C)CC1.CCN1CCN(S(=O)(=O)C(C)C)CC1.
What is the InChIKey of N,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine?
The InChIKey is UDXYIYSWTVLRRK-UHFFFAOYSA-N. The full InChI is InChI=1S/2C10H22N2O2S.C9H17F3N2O2S.4C9H20N2O2S.C9H19NO2S.2C8H18N2O2S.C8H17NO3S.C8H17NO2S.2C7H16N2O2S.C7H15NO3S.C7H15NO2S.C5H11NO2S/c2*1-4-11-6-5-7-12(9-8-11)15(13,14)10(2)3;1-8(2)17(15,16)14-5-3-13(4-6-14)7-9(10,11)12;1-8(2)14(12,13)11-6-5-9(7-11)10(3)4;1-9(2)14(12,13)11-6-4-5-10(3)7-8-11;1-8(2)14(12,13)11-6-4-5-10-7-9(11)3;1-4-10-5-7-11(8-6-10)14(12,13)9(2)3;1-9(2)13(11,12)10-7-5-3-4-6-8-10;1-8(2)13(11,12)10-6-4-9(3)5-7-10;1-8(2)13(11,12)10-6-3-4-9-5-7-10;1-8(2)13(10,11)9-4-3-6-12-7-5-9;1-8(2)12(10,11)9-6-4-3-5-7-9;1-7(2)12(10,11)9-5-3-8-4-6-9;1-6(2)12(10,11)9-4-3-7(8)5-9;1-7(2)12(9,10)8-3-5-11-6-4-8;1-7(2)11(9,10)8-5-3-4-6-8;1-5(2)9(7,8)6-3-4-6/h2*10H,4-9H2,1-3H3;8H,3-7H2,1-2H3;8-9H,5-7H2,1-4H3;9H,4-8H2,1-3H3;8-10H,4-7H2,1-3H3;9H,4-8H2,1-3H3;9H,3-8H2,1-2H3;8H,4-7H2,1-3H3;8-9H,3-7H2,1-2H3;8H,3-7H2,1-2H3;8H,3-7H2,1-2H3;7-8H,3-6H2,1-2H3;6-7H,3-5,8H2,1-2H3;7H,3-6H2,1-2H3;7H,3-6H2,1-2H3;5H,3-4H2,1-2H3.
What are the key properties of N,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine?
N,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine has a molecular weight of 3545.25 g/mol, XLogP of 7.46, 39 rotatable bonds, 4 hydrogen bond donors, and 47 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-dimethyl-1-propan-2-ylsulfonylpyrrolidin-3-amine;bis(1-ethyl-4-propan-2-ylsulfonyl-1,4-diazepane);1-ethyl-4-propan-2-ylsulfonylpiperazine;1-methyl-4-propan-2-ylsulfonyl-1,4-diazepane;2-methyl-1-propan-2-ylsulfonyl-1,4-diazepane;1-methyl-4-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylazepane;1-propan-2-ylsulfonylaziridine;1-propan-2-ylsulfonyl-1,4-diazepane;4-propan-2-ylsulfonylmorpholine;4-propan-2-ylsulfonyl-1,4-oxazepane;1-propan-2-ylsulfonylpiperazine;1-propan-2-ylsulfonylpiperidine;1-propan-2-ylsulfonylpyrrolidin-3-amine;1-propan-2-ylsulfonylpyrrolidine;1-propan-2-ylsulfonyl-4-(2,2,2-trifluoroethyl)piperazine is sourced from PubChem (CID 161065223), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).